Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2022-09-01
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Statistics Data will be analyzed using graphing and statistical analysis software. Independent t test will be applied to calculate continuous variables in demographic values, while Chi-square will be applied to calculate categorical variables such as postoperative complications. A probability of less than 0.05 will be considered significant.
Potential risks: No
Confidentiality:
All the patient identifiable information, which includes name, chart number and birthday, involved in the study will be strictly confidential.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nipple-sparing Mastectomy in Combined With Buried Flap Monitoring
NCT05560633
Autologous Nerve Graft Breast Reconstruction Neurotization
NCT06629012
Split Chest Breast Neurotization
NCT05757778
Successful Microsurgical Breast Reconstruction in Minimally Invasive Mastectomy
NCT05943873
Preoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing Mastectomy
NCT06071234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurotized
No interventions assigned to this group
Non-neurotized
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients who received breast reconstruction without neurotization were included as the non-neurotized group.
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung-Ju Huang
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ChangGungMH
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202201302B0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.